Therefore, following PRMT1 knockdown in GC cells, the observed changes in M1 and M2 macrophages within tumors may be attributed to the production of IFN-β downstream of the cGAS-STING pathway in GC cells. The gene discussed is CGAS; the disease is gastric cancer.